Sponsorizzato
Fabry Disease Treatments 2025: What's Ahead in the Pipeline
Fabry disease is a rare, X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to a deficiency of the enzyme alpha-galactosidase A (α-Gal A). This enzyme is responsible for breaking down globotriaosylceramide (GL-3 or Gb3), a complex lipid. Enzyme deficiency results in systemic accumulation of Gb3 and related glycosphingolipids, particularly in vascular...
0 Commenti 0 condivisioni 43 Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato